| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/26/2008 | CN100376239C Use of medicine composition in preparation of medicine and food dual purpose nutritive product for preventing and treating cataract |
| 03/26/2008 | CN100376238C Use of medicine and food dual purpose composition in preparation of nutritive product for preventing pseudomyopia and real myopia |
| 03/26/2008 | CN100376232C Anaesthetic formulations |
| 03/26/2008 | CN100376231C Compound grease-reducing drop pills preparation method |
| 03/26/2008 | CN100376230C Timing slow-releasing micrpill and its preparation |
| 03/26/2008 | CN100376229C A medicinal wine for treating rheumatic and rheumatoid disease |
| 03/26/2008 | CN100376228C Method for extracting embryonic nutrient and beauty product |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348364 Segmented copolyesters as compliant, absorbable coatings and sealants for vascular devices |
| 03/25/2008 | US7348362 Bronchodilating β-agonist compositions and methods |
| 03/25/2008 | US7348360 Method and composition for delivering zinc to the nasal membrane |
| 03/25/2008 | US7348329 Use of 5-[4-[[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione or N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine; dry eyes, corneal ulcer, keratitis, conjunctivitis |
| 03/25/2008 | US7348317 Aqueous compositions containing metronidazole |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348306 Peptide with a sequence selected from the group consisting of Ser-Leu-Ile-Gly-Arg-Leu-NH2, and trans-cynnamoyl-Leu-Ile-Gly-Arg-Leu-ornithine-NH2 combined with amastatins for activation of protease activated receptor-2; eye drop solution for contact lenses |
| 03/25/2008 | US7348032 Using plant extracts as antiproliferative agents |
| 03/25/2008 | US7348031 Method for preparing colloidal particles in the form of nanocapsules |
| 03/25/2008 | US7348030 Nanoparticles for targeting hepatoma cells |
| 03/25/2008 | US7348029 Coating with modified polyoxyethylene glycol in solvent |
| 03/25/2008 | US7348028 Treating or preventing myocardial ischemia and angina pectoris; time-release Galenical preparation |
| 03/25/2008 | US7348027 Taste masked veterinary formulation |
| 03/25/2008 | US7348026 Administering a dose of therapeutically effective amount of nanoparticles to the patient, wherein nanoparticles comprise gamma -polyglutamic acid-polylactic acid block copolymers conjugated with galactosamin fpr therapy of liver cancer |
| 03/25/2008 | US7348025 Small particle liposome aerosols for delivery of anticancer drugs |
| 03/25/2008 | US7348024 Pull apart fragrance sampler |
| 03/25/2008 | US7348021 Immunostimulating coating for surgical devices |
| 03/25/2008 | US7348016 Self-reversible reverse microlatex, process for preparing the same and cosmetic and industrial uses thereof |
| 03/25/2008 | US7347854 Method and apparatus for automatically modifying delivery profile of drug delivery system |
| 03/25/2008 | US7347850 Adhesion barriers applicable by minimally invasive surgery and methods of use thereof |
| 03/25/2008 | US7347843 Vascular access port with needle detector |
| 03/25/2008 | US7347819 Ambulatory medical apparatus and method using a robust communication protocol |
| 03/25/2008 | US7347199 Pressurised metered dose inhalers (MDI) |
| 03/25/2008 | CA2432203C Sustained release drug delivery devices with multiple agents |
| 03/25/2008 | CA2419077C A method of treating a systemic disease |
| 03/25/2008 | CA2371178C Prucalopride oral solution |
| 03/25/2008 | CA2343123C Active substance concentrate with formoterol, suitable for storage |
| 03/25/2008 | CA2327522C Incorporation of active substances in carrier matrixes |
| 03/25/2008 | CA2319217C Pharmaceutical compositions |
| 03/25/2008 | CA2312736C Tablet production method and tablet |
| 03/25/2008 | CA2291796C Therapeutically active compositions |
| 03/25/2008 | CA2275153C Pharmaceutical compositions for freeze drying |
| 03/20/2008 | WO2008033523A1 Abuse resistant drug formulation |
| 03/20/2008 | WO2008033497A1 Nanostructured smart gel for time release drug delivery |
| 03/20/2008 | WO2008033487A2 Method for preparing solid dosage forms that form a paste, cream or gel when diluted for final use |
| 03/20/2008 | WO2008033477A2 Antimicrobial activity in variants of lacritin |
| 03/20/2008 | WO2008033462A2 Supple tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan |
| 03/20/2008 | WO2008033426A1 Injector apparatus and method of use |
| 03/20/2008 | WO2008033351A2 Multimodal abuse resistant and extended release formulations |
| 03/20/2008 | WO2008033300A2 Bis (thiohydrazide amides) formulation |
| 03/20/2008 | WO2008033227A2 Optically clear nanoparticle colloidal suspensions and method of making thereof |
| 03/20/2008 | WO2008033031A2 Mri trackable drug delivery particles, uses and methods thereof |
| 03/20/2008 | WO2008033024A2 Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| 03/20/2008 | WO2008032767A1 Orally disintegrating tablet and process for production thereof |
| 03/20/2008 | WO2008032726A1 Solid pharmaceutical composition for oral administration comprising optically stable ramosetron |
| 03/20/2008 | WO2008032719A1 Adhesive preparation |
| 03/20/2008 | WO2008032718A1 Adhesive preparation |
| 03/20/2008 | WO2008032678A1 Adhesive preparation |
| 03/20/2008 | WO2008032432A1 Gel type enteric nutrient |
| 03/20/2008 | WO2008032327A2 Organic nanoparticles obtained from microemulsions by solvent evaporation |
| 03/20/2008 | WO2008032183A2 Rapidly disintegrating dosage form |
| 03/20/2008 | WO2008032022A2 Composition for photoprotection |
| 03/20/2008 | WO2008031886A1 Process for preparing granules of hydrophilic vitamins |
| 03/20/2008 | WO2008031782A1 Pharmaceutical composition comprising a plurality of mini-tablets comprising a factor xa inhibitor |
| 03/20/2008 | WO2008031770A2 Pharmaceutical compositions for the oral or rectal administration of protein substances |
| 03/20/2008 | WO2008031631A2 Oral modified release formulations |
| 03/20/2008 | WO2008031623A1 Pharmaceutical formulations comprising clopidogrel |
| 03/20/2008 | WO2008031513A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivates as stimulators of guanylate cyclase for cardiovascular disorders |
| 03/20/2008 | WO2008031465A1 Nano-vehicle for the transcutaneous transport, preparation containing the same and its use |
| 03/20/2008 | WO2008031358A1 1,2-dihydroxy-3-methyl-9,10-anthraquinone in the manufacture of medicaments for treating cancers |
| 03/20/2008 | WO2008031357A1 (3z)-3-(1h-pyrrol-2-ylmethylene)-1,3-dihydro-2h-indol-2-one in manufacture of medicaments for treating cancers |
| 03/20/2008 | WO2008031332A1 Use of fucoidan in preparation of medicaments for the treatment of cardiovascular and cerebrovascular diseases |
| 03/20/2008 | WO2008031322A1 Application of acetylcholine esterase inhibitor medication of leonurus extractive as cholinomimetic |
| 03/20/2008 | WO2008031285A1 Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process |
| 03/20/2008 | WO2008031188A1 Vitamin d compositions and method of administration to a human being |
| 03/20/2008 | WO2008031182A1 Process for synthesis and incorporation of nitric oxide donors in macromolecular compositions |
| 03/20/2008 | WO2008031157A1 Acetylenic compounds |
| 03/20/2008 | WO2008015238A3 Subcutaneous implants releasing an active principle over an extended period of time |
| 03/20/2008 | WO2008013822A3 Parenteral preparations of gi-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 03/20/2008 | WO2007149864A3 Non-hormonal vaginal contraceptive |
| 03/20/2008 | WO2007149801A3 Enteric coated particles containing an active ingredient |
| 03/20/2008 | WO2007146514A3 System for monitoring of patients |
| 03/20/2008 | WO2007146288A3 Methods for the formulation and manufacture of artesunic acid for injection |
| 03/20/2008 | WO2007143131A3 Prednisolone sodium phosphate formulations |
| 03/20/2008 | WO2007141743A3 A tablet dosage form comprising cetirizine and pseudoephedrine |
| 03/20/2008 | WO2007135224B1 Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products |
| 03/20/2008 | WO2007132328A3 Novel galenic forms of artemisin and its derivatives in combination with other antimalarial agents for treating malaria |
| 03/20/2008 | WO2007130134A3 Controlled release microparticles |
| 03/20/2008 | WO2007121207A3 Therapeutic belt |
| 03/20/2008 | WO2007115169A3 Polymeric materials as stomach filler and their preparation |
| 03/20/2008 | WO2007108883A3 High-deposition compositions and uses thereof |
| 03/20/2008 | WO2007106594A3 System and method for percutaneously administering reduced pressure treatment using a flowable manifold |
| 03/20/2008 | WO2007089902A3 Compositions and methods for promoting the healing of tissue of multicellular organisms |
| 03/20/2008 | WO2007075422A3 Ph modulated films for delivery of actives |
| 03/20/2008 | WO2007064857A8 Amphoteric liposome formulation |
| 03/20/2008 | WO2007052076A3 Formulations comprising jorumycin-, reni eramycin-, safracin- or saframycin-related compounds for treating proliferative diseases |
| 03/20/2008 | WO2007048599A3 Drug-delivery systems |
| 03/20/2008 | WO2007023396A3 Vasoactive kit and composition and uses thereof |
| 03/20/2008 | WO2007016791A8 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 03/20/2008 | WO2007010501A3 A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor |
| 03/20/2008 | WO2006120226A8 Stabilizer molecule-depleted albumin solution |
| 03/20/2008 | WO2005044224A3 Drug delivery system based on polymer nanoshells |